Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1938]
News [3134]
Articles [127]
Editorials [3]
Conferences [119]
elearning [13]
Targeting tyrosine kinase receptors to tackle CML
Prof Michael Deininger - University of Utah, Salt Lake City, USA
Targeting tyrosine kinase receptors to tackle CML ( Prof Michael Deininger - University of Utah, Salt Lake City, USA )
13 Dec 2013
Chronic lymphocytic leukaemia: A new treatment era is born
Dr John Gribben - Barts Cancer Institute, London, UK
Chronic lymphocytic leukaemia: A new treatment era is born ( Dr John Gribben - Barts Cancer Institute, London, UK )
13 Dec 2013
Chemo-free treatment for acute promyelocytic leukaemia
Dr Luca Mazzarella - European Institute of Oncology, Milan, Italy
Chemo-free treatment for acute promyelocytic leukaemia ( Dr Luca Mazzarella - European Institute of Oncology, Milan, Italy )
13 Dec 2013
Initial phase III results of the first trial in newly diagnosed multiple myeloma
Dr Thierry Facon - Centre Hospitalier Régional Universitaire de Lille, France
Initial phase III results of the first trial in newly diagnosed multiple myeloma ( Dr Thierry Facon - Centre Hospitalier Régional Universitaire de Lille, France )
10 Dec 2013
Lenalidomide promotes CRBN-mediated ubiquitination and degradation of IKZF1 and...
Dr Jan Krönke - Brigham and Women's Hospital, Boston, USA
Lenalidomide promotes CRBN-mediated ubiquitination and degradation of IKZF1 and IKZF3 ( Dr Jan Krönke - Brigham and Women's Hospital, Boston, USA )
8 Dec 2013
Treating ALL patients with T cells targeted for CD19
Dr Laurence Cooper - MD Anderson Cancer Center, Houston, USA
Treating ALL patients with T cells targeted for CD19 ( Dr Laurence Cooper - MD Anderson Cancer Center, Houston, USA )
8 Dec 2013
Long-term functional persistence, B cell aplasia and anti-leukaemia efficacy in...
Dr Michael Kalos - University of Pennsylvania, Philadelphia, USA
Long-term functional persistence, B cell aplasia and anti-leukaemia efficacy in refractory B cell malignancies ( Dr Michael Kalos - University of Pennsylvania, Philadelphia, USA )
8 Dec 2013
T cells engineered with chimeric antigen receptor targeting CD19 produce...
Dr Stephen A. Grupp - University of Pennsylvania, Philadelphia, USA
T cells engineered with chimeric antigen receptor targeting CD19 produce significant long-term persistence ( Dr Stephen A. Grupp - University of Pennsylvania, Philadelphia, USA )
8 Dec 2013
Removal of alpha/beta T cells and of CD19 B cells in children With acute...
Dr Alice Bertaina - IRCCS Bambino Gesù Children's Hospital, Rome, Italy
Removal of alpha/beta T cells and of CD19 B cells in children With acute leukaemia ( Dr Alice Bertaina - IRCCS Bambino Gesù Children's Hospital, Rome, Italy )
8 Dec 2013
Transplantation and short telomeres increase the risk of cognitive impairment
Dr Smita Bhatia - City of Hope National Medical Center, Duarte, California
Transplantation and short telomeres increase the risk of cognitive impairment ( Dr Smita Bhatia - City of Hope National Medical Center, Duarte, California )
8 Dec 2013
Study of the efficacy and safety of siltuximab, an anti-interleukin-6...
Dr Raymond Wong - Chinese University of Hong Kong
Study of the efficacy and safety of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with multicentric Castleman’s disease ( Dr Raymond Wong - Chinese University of Hong Kong )
8 Dec 2013
Results from the randomised phase III Children’s Oncology Group (COG) trial...
Dr Alan Gamis - Children’s Mercy Hospital, Kansas City, USA
Results from the randomised phase III Children’s Oncology Group (COG) trial, AAML0531 ( Dr Alan Gamis - Children’s Mercy Hospital, Kansas City, USA )
8 Dec 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation